Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients

Ozden M. Ö., Maral H., Akaydin D., Cetinalp P., Kalender B.

CLINICAL BIOCHEMISTRY, vol.35, no.4, pp.269-273, 2002 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 4
  • Publication Date: 2002
  • Doi Number: 10.1016/s0009-9120(02)00307-7
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.269-273
  • Keywords: continuous ambulatory peritoneal dialysis, hemodialysis, glutathione, glutathione peroxidase, malondialdehyde, CHRONIC-RENAL-FAILURE, PERITONEAL-DIALYSIS PATIENTS, LIPID-PEROXIDATION, EXCRETION, URINE, ABNORMALITIES, FORMALDEHYDE, ACETALDEHYDE, CONSEQUENCE, MECHANISM
  • Kocaeli University Affiliated: Yes


Objectives: Cardiovascular disease is the major cause of mortality in patients receiving hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) due to chronic renal failure. Increased lipid peroxidation and depletion of antioxidants may contribute to increased risk of atherosclerosis. We have therefore assessed the effect of hemodialysis and CAPD on oxidant and antioxidant status.